Viewing Study NCT03015792


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2026-01-29 @ 9:37 PM
Study NCT ID: NCT03015792
Status: TERMINATED
Last Update Posted: 2025-08-17
First Post: 2017-01-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: